Guardian Pharmacy Services, Inc. (GRDN)
| Market Cap | 2.40B +76.6% |
| Revenue (ttm) | 1.45B +17.9% |
| Net Income | 49.22M |
| EPS | 0.78 |
| Shares Out | 63.32M |
| PE Ratio | 48.78 |
| Forward PE | 30.96 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 389,562 |
| Open | 38.15 |
| Previous Close | 37.57 |
| Day's Range | 37.91 - 39.62 |
| 52-Week Range | 19.17 - 41.36 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 40.60 (+7.04%) |
| Earnings Date | May 6, 2026 |
About GRDN
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, tr... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for GRDN stock is "Strong Buy." The 12-month stock price target is $40.6, which is an increase of 7.04% from the latest price.
News
Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) will be attending the Bank of America 2026 Healthcare Conference in Las Vegas on Wednesday, May 13, 2026. Fred Burke, President ...
Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Manageme...
Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the “Offering”) of 6,000,000 shares of its...
Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its C...
Guardian Pharmacy Services Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Strong Q4 momentum was driven by vaccine clinics, acquisitions, and operational optimization. Guidance was raised on robust vaccine performance, with IRA headwinds expected to diminish. Growth is supported by demographic trends, M&A, and innovative clinical programs, while strong cash flow enables continued expansion.
Guardian Pharmacy Services Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 results exceeded expectations, with 18% revenue growth and 27% adjusted EBITDA growth year-over-year. Raised 2026 EBITDA guidance to $120–$124 million, maintaining strong cash flow and robust M&A pipeline amid industry changes.
Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the f...
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred ...
Guardian Pharmacy Services Transcript: 47th Annual Raymond James Institutional Investor Conference
A leading assisted living pharmacy provider is leveraging organic growth, disciplined M&A, and a tech-enabled service model to expand its 13% market share. Strong financials, high adoption rates, and proactive regulatory engagement position it for continued growth amid favorable demographic trends.
Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will present at the Raymond James Institutional Investors Conference in Orlando, Florida on Mon...
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March ...
Guardian Pharmacy Services Transcript: 44th Annual J.P. Morgan Healthcare Conference
A leading long-term care pharmacy provider for assisted living facilities, the company leverages technology, data analytics, and a disciplined growth strategy to expand its 13% market share. Despite regulatory headwinds from the Inflation Reduction Act, it projects continued EBITDA growth and strong cash flow, supported by organic expansion and targeted M&A.
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation's leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance...
Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The comp...
Guardian Pharmacy Services Transcript: Stephens Annual Investment Conference
The conference highlighted a strategy focused on assisted living, leveraging clinician-led, tech-enabled services and advanced analytics to drive organic and inorganic growth. Regulatory headwinds from the IRA are being offset, and expansion into adjacent markets like PACE and hospice is underway. Key profitability improvements stem from operational integration and service innovation.
Guardian Pharmacy Services Earnings Call Transcript: Q3 2025
Achieved 20% revenue growth and 19% adjusted EBITDA growth year-over-year, raising full-year guidance for both metrics. Recent acquisitions and organic growth drove results, with steady margins and strong cash generation supporting ongoing expansion.
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the t...
Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025...
Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) (“Guardian”), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a ...
Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host ...
Guardian Pharmacy Services Transcript: Jefferies 2025 Healthcare Services Conference
A specialized pharmacy provider for assisted living is leveraging its market leadership, scale, and tech-enabled services to drive double-digit growth through organic expansion and M&A. Strategic focus on reimbursement, regulatory mitigation, and adjacent markets supports a strong financial profile and differentiates it from legacy competitors.
Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference in Nashville, TN, on Tuesday, September...
Guardian Pharmacy Services Earnings Call Transcript: Q2 2025
Q2 2025 saw double-digit growth in revenue, resident count, and adjusted EBITDA, with strong organic and acquisition-driven expansion. Guidance for full-year revenue and EBITDA was raised, while policy risks from the IRA and PBM negotiations are being proactively managed.
Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the s...
Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Managed Healthcare Pharmacy, a leading long-term care pharmacy in Oregon.